StonvexLoading…
StonvexStonvexStonvexCore line items from CLH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.65B | $1.46B | $6.03B | $4.53B | $2.98B |
Operating Income | Not available | $118.94M | $673.37M | $514.93M | $321.92M |
Net Income | Not available | $63.20M | $390.97M | $304.38M | $126.91M |
EPS (Diluted) | $2.77 | $1.19 | $7.28 | $5.65 | $3.44 |
Total Assets | Not available | $7.55B | $7.62B | $7.54B | $7.44B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $547.99M | $826.32M | $759.20M | $600.19M |
Free Cash Flow OCF − CapEx | Not available | $-92.15M | $441.81M | $208.46M | $921.00K |
Shares Outstanding | Not available | 52.83M | 52.87M | 53.43M | 53.61M |